Tachykinins and excitotoxicity in cerebellar granule cells

Cerebellum

Volumn 5, Issue 3, 2006, Pages 232-237

  Severini, Cinzia ^a,b   Zona, Cristina ^b  

^a Institute of Neurobiology and Molecular Medicine   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Excitotoxicity; Glutamate receptors; NKA; NKB; Substance P

Indexed keywords

GLUTAMATE RECEPTOR; NEUROPEPTIDE; TACHYKININ DERIVATIVE;

CENTRAL NERVOUS SYSTEM; CEREBELLUM; EXCITOTOXICITY; GRANULE CELL; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; CEREBELLUM; EXCITATORY AMINO ACIDS; HUMANS; NEURONS; SYNAPTIC TRANSMISSION; TACHYKININS;

EID: 33748997071     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1080/14734220600673295     Document Type: Review

References (73)

1. Ingi T, Kitajima Y, Minamitake Y, Nakanishi S. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells. J Pharmacol Exp Ther. 1991;259:968-75.
2. Maggi CA. The mammalian tachykinin receptors. General Pharmacol. 1995;26:911-44.
3. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev. 1994;46:551-99.
4. Longmore J, Hill RG, Hargreaves RJ. Neurokinin-receptor antagonists: Pharmacological tools and therapeutic drugs. Can. J Phys Pharm. 1997;75:612-21.
5. Ogier R, Raggenbass M. Action of tachykinins in the rat hippocampus: Modulation of inhibitory synaptic transmission. Eur J Neurosci. 2003;17:2639-47.
6. Yang YL, Yao KH, Li ZW. Similarities of SP-, NKA- and NKB- induced currents in rat dorsal root ganglion neurons. Brain Res. 2003;991:18-25.
7. Hill RG. Substance P, opioid, and catecholamine system in the mouse central nervous system (CNS). PNAS. 2002;99:549-51.
8. Quartara L, Maggi CA. The tachykinin NK1 receptor. Part II: Distribution and pathophysiology roles. Neuropeptides. 1998;32:1-49.
9. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonist. Trends Pharmacol Sci. 1999;20:485-490.
10. Saria A. The tachykinin NK1 receptor in the brain: Pharmacology and putative functions. Eur J Pharmacol. 1999;375:51-60.
11. Raffa RB. Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders. Neurosci Biobehav Rev. 1998;22:789-813.
12. Severini C, Ciotti MT, Mercanti D, Barbato C, Calissano P. A tachykinin-like factor increases glutamate toxicity in rat cerebellar granule cells. Neuropharmacol. 2003;44:117-24.
13. Beal MF. Mechanism of excitatory in neurologic disease. FASEB J. 1992;6:3338-44.
14. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31-108.
15. Blandini F, Porter RH, Greenamyre JT. Glutamate and Parkinson's disease. Mol Neurobiol. 1996;12:73-94.
16. Lipton SA, Rosemberg PA. Excitatory amino acids as a final common pathway for neurological disorders. New Eng J Med. 1994;330:613-22.
17. Pieri M, Severini C, Amadoro G, et al. AMPA receptors are modulated by tachykinins in rat cerebellum neurons. J Neurophysiol. 2005;94:2484-90.
18. Nawa H, Kotani H, Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984;312:729-34.
19. Kotani H, Hoshimaru M, Nawa H, Nakanishi S. Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci USA. 1986;83:7074-8.
20. MacDonald MR, McCourt DW, Krause JE. Posttranslational processing of alpha-, beta-, and gamma-preprotachykinins. Cell-free translation and early posttranslational processing events. J Biol Sci. 1988;263:15176-83.
21. Carter MS, Krause JE. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma. J Neurosci. 1990;10:2203-14.
22. Page NM, Woods RJ, Gardiner SM, et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 2000;405:797-800.
23. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: A growing family. Life Sci. 2004;74:1445-63.
24. Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nature Immunol. 2000;1:392-7.
25. Kurtz MM, Wang R, Clements M, et al. Identification, localization and receptor characterization of novel mammalian substance-P peptides. Gene. 2002;296:205-12.
26. Page NM, Woods RJ, Gardiner SM, et al. Characterization of the endokinins: Human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA. 2003;100:6245-50.
27. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. Three rat reprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA. 1987;84:881-5.
28. Holmgren S, Jensen J. Evolution of vertebrate neuropeptides. Brain Res Bull. 2001;55:723-35.
29. Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol. 2001;33:555-76.
30. Severini C, Improta G, Falconieri-Erspamer G, Salvatori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev. 2002;54:1-38.
31. Hokfelt T, Holets VR, Staines W, et al. Coexistence of neuronal messengers: An overview. Prog Brain Res. 1986;68:33-70.
32. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev. 1993;73:229-308.
33. Page NM. Hemokinins and endokinins. Cell Mol Life Sci. 2004;61:1652-63.
34. Tsukida K, Shigemoto R, Yokota Y, Nakanishi S. Tissue distribution and quantitation of the mRNAs for the three rat tachykinin receptors. Eur J Biochem. 1990;193:751-7.
35. Merchenthaler I, Maderdrut JL, O'Harte F, Conlon JM. Localization of neurokinin B in the central nervous system of the rat. Peptides. 1992;13:815-29.
36. Kaneko T, Murashima M, Lee T, Mizuno N. Characterization of neocortical non-pyramidal neurons expressing preprotachykinin A and B: a double immunofluorescence study in the rat. Neuroscience. 1998;86:765-81.
37. Maggi CA. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Peptides. 2000;93:53-64.
38. Barbato C, Ciotti MT, Serafino A, Severini C, Calissano P. Tachykinin neuropeptides in cerebellar granule neurons: an immunocytochemical study. Eur J Histochem. 2005;49:87-92.
39. Aita M, Seo K, Fujiwara N, Takagi R, Maeda T. Postnatal changes in the spatial distributions of substance P and NK1 receptor in the trigeminal subnucleus caudalis of mice. Brain Res Dev Brain Res. 2005;155:33-41.
40. Baloyannis SJ, Costa V, Deretzi G, Michmizos D. Intraventricular administration of substance P increases the dendritic arborisation and the synaptic surfaces of Purkinje cells in rat's cerebellum. Int J Neurosci. 2000;101:89-107.
41. Mussap CJ, Geraghty DP, Burcher E. Tachykinin receptors: A radioligand binding perspective. J Neurochem. 1993;60:1987-2009.
42. Krause JE, Blount P, Sachais BS. Molecular biology of receptors. Structure., expression and regulatory mechanisms. In: Buck SH, editor. The tachykinin receptors. New York: Humana Press; 1994. pp 165-218.
43. Guard S, Watson SP. Tachykinin receptor types: Classification membrane signalling mechanism. Neurochem Int. 1991;18:149-65.
44. Takeda Y, Blount P, Sachais BS, Hershey AD, Raddatz R, Krause JE. Ligand binding kinetics of substance P and neurokinin A receptors stably expressed in Chinese hamster ovary cells and evidence for differential stimulation of inositol 1,4,5-trisphosphate and cyclic AMP second messenger responses. J Neurochem. 1992;59:740-5.
45. Mochizuki-Oda N, Nakajima Y, Nakanishi S, Ito S. Characterization of the substance P receptor-mediated calcium influx in cDNA transfected Chinese hamster ovary cells. A possible role of inositol 1,4,5-trisphosphate in calcium influx. J Biol Chem. 1994;269:9651-8.
46. Nakajima Y, Tsukida K, Nagishi M, Ito S, Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Sci. 1992;267:2437-42.
47. Palanche T, Ilien B, Zoffmann S, et al. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem. 2001;276:34853-61.
48. Stumm R, Culmsee C, Schafer MKH, Krieglstein J, Wheihe E. Adaptative plasticity in tachykinin receptor expression after focal cerebral ischemia is differentially linked to GABAergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium. J Neurosci. 2001;21:798-811.
49. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptors ion channels. Pharmacol Rev. 1999;51:7-61.
50. Limatola C. Neurotrophic effects of AMPA. Cerebellum. 2003;2:2-10.
51. Schwarzer C, Williamson JM, Lothman EW, Vezzani A, Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neurosci. 1995;69:831-45.
52. Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG. Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. PNAS. 1999;96:5286-91.
53. Maubach KA, Cody C, Jones RSG. Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition. Neurosci. 1998;83:1047-62.
54. Marksteiner J, Wahler R, Bellmann R, Ortler M, Krause JE, Sperk G. Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat. Neurosci. 1992;49:383-95.
55. Bailey CP, Maubach KA, Jones RSG. Neurokinin-1 receptors in the rat nucleus tractus solitarius: pre- and postsynaptic modulation of glutamate and GABA release. Neurosci. 2004;127:467-79.
56. Shen KZ, North RA. Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons. Neurosci. 1992;50:345-53.
57. Bell MI, Richardson PJ, Lee K. Characterization of the mechanism of action of tachykinins in rat striatal cholinergic interneurons. Neurosci. 1998;87:649-58.
58. Sculptoreanu A, de Groat W. Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG Neurons of the adult rat. J Neurophysiol. 2003;90:21-31.
59. Barker R. Tachykinins, neurotrophism and neurodegenerative disorders: A critical review on the possible role of tachykinins in the aetiology of CNS disease. Rev Neurosci. 1996;7:187-214.
60. Kemel ML, Perez S, Godeheu G, Soubrie P, Glowinski J. Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J Neurosci. 2002;22:1929-36.
61. Chizh BA, Cumberbatch MJ, Birch PJ, Headley PM. Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord. Br J Pharmacol. 1995;115:1013-19.
62. Kouznetsova M, Nistri A. Modulation by substance P of synaptic transmission in the mouse hippocampal slice. Eur J Neurosci. 1998;10:3076-84.
63. Burnashev N, Monyer H, Seeburg PH, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 1992;8:189-98.
64. Geiger JR, Melcher T, Koh DS, et al. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. 1995;15:193-204.
65. Vanderberghe W, Robberecht W, Brorson JR. AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. J Neurosci. 2000;20:123-32.
66. Weiss JH, Sensi SL. Ca2+-Zn2+ permeable AMPA or kainate receptor: possible key factors in selective neurodegeneration. Trends Neurosci. 2000;23:365-71.
67. Liu S, Lau L, Wei J, Zhu D, Zou S, Sun HS, Fu Y, Liu F, Lu Y. Expression of Ca(2+)- permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron. 2004;43:43-55.
68. Balojannis SJ, Costa V, Deretzi G, Michmizos D. Intraventricular administration of Substance P increases the dendritic arborisation and the synaptic surfaces of Purkinje cells in rat's cerebellum. Int J Neurosci. 2000;101:89-107.
69. Yacubova E, Komuro H. Intrinsic program for migration of cerebellar granule cells in vitro. J Neurosci. 2002;22:5966-81.
70. Wetts R, Herrup K. Direct correlation between Purkinje and granule cell number in the cerebella of lurcher chimeras and wild-type mice. Brain Res. 1983;312:41-7.
71. Oppenheim RW. Cell death during the development of the nervous system. Annu Rev Neurosci. 1991;14:453-501.
72. Altmann J. Morphological development of the rat cerebellum and some of its mechanisms. Exp Brain Res. 1982;6:8-49.
73. Inagaki S, Sakanaka M, Shiosaka S, Senba E, Takagi H, Takatsuki K, Kawai Y, Matsuzaki T, Iida H, Hara Y, Tohyama M. Experimental and immunohistochemical studies on the cerebellar substance P of the rat: Localization, postnatal ontogeny and ways of entry to the cerebellum. Neuroscience. 1982;7:639-45.